Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Total Current Liabilities (2016 - 2025)

INVO Fertility (IVF) has disclosed Total Current Liabilities for 15 consecutive years, with $9.2 million as the latest value for Q3 2025.

  • Quarterly Total Current Liabilities rose 6.81% to $9.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Sep 2025, up 6.81% year-over-year, with the annual reading at $17.9 million for FY2024, 124.0% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $9.2 million at INVO Fertility, down from $12.5 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $18.7 million in Q1 2025, with the low at $1.0 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $6.3 million, with a median of $4.5 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities plummeted 48.67% in 2021, then surged 341.72% in 2023.
  • Over 5 years, Total Current Liabilities stood at $1.2 million in 2021, then soared by 184.2% to $3.3 million in 2022, then skyrocketed by 139.75% to $8.0 million in 2023, then skyrocketed by 124.0% to $17.9 million in 2024, then tumbled by 48.43% to $9.2 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $9.2 million, $12.5 million, and $18.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.